Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial C Davies, H Pan, J Godwin, et al The Lancet 381 (9869), 805-816, 2013 | 2492 | 2013 |
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE) SRD Johnston, N Harbeck, H R, et al J Clin Oncol 38 (34), 3987-3998, 2020 | 665 | 2020 |
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ... Annals of oncology 19 (3), 420-432, 2008 | 586 | 2008 |
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells JA Menendez, L Vellon, I Mehmi, BP Oza, S Ropero, R Colomer, R Lupu Proceedings of the National Academy of Sciences 101 (29), 10715-10720, 2004 | 418 | 2004 |
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation R Porta, JM Sanchez-Torres, L Paz-Ares, B Massuti, N Reguart, C Mayo, ... European Respiratory Journal 37 (3), 624-631, 2011 | 401 | 2011 |
International conference on the healthy effect of virgin olive oil Jaen European journal of clinical investigation 35 (7), 421-424, 2005 | 357 | 2005 |
N-3 fatty acids, cancer and cachexia: a systematic review of the literature R Colomer, JM Moreno-Nogueira, PP Garcıa-Luna, P Garcıa-Peris, ... Br J Nutr 97 (5), 823-831, 2007 | 352 | 2007 |
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab … JA Menendez, L Vellon, R Colomer, R Lupu Annals of oncology 16 (3), 359-371, 2005 | 341 | 2005 |
Direct Interaction of a Ligand for the erbB2 Oncogene Product with the EGF Receptor and p185erbB2 R Lupu, R Colomer, G Zugmaier, J Sarup, M Shepard, D Slamon, ... Science 249 (4976), 1552-1555, 1990 | 330 | 1990 |
Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer: the NEfERT-T randomized clinical trial A Awada, R Colomer, K Inoue, I Bondarenko, RA Badwe, G Demetriou, ... JAMA oncology 2 (12), 1557-1564, 2016 | 324 | 2016 |
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim … SRD Johnston, M Toi, J O'Shaughnessy, et al, EC Members Lancet Oncol 24 (1), 77-90, 2023 | 243 | 2023 |
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ... BMC cancer 7, 1-19, 2007 | 231 | 2007 |
Pertuzumab, trastuzumab, and standard anthracycline-and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE … SM Swain, MS Ewer, G Viale, S Delaloge, JM Ferrero, M Verrill, ... Annals of oncology 29 (3), 646-653, 2018 | 230 | 2018 |
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez Cell proliferation 41 (1), 59-85, 2008 | 230 | 2008 |
Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients J Rogado, JM Sánchez-Torres, N Romero-Laorden, AI Ballesteros, ... European Journal of Cancer 109, 21-27, 2019 | 226 | 2019 |
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer R Colomer, S Montero, A Lluch, B Ojeda, A Barnadas, A Casado, ... Clinical Cancer Research 6 (6), 2356-2362, 2000 | 223 | 2000 |
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner S Mañes, E Mira, R Colomer, S Montero, LM Real, C Gómez-Moutón, ... The Journal of experimental medicine 198 (9), 1381, 2003 | 209 | 2003 |
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells JA Menendez, M del Mar Barbacid, S Montero, E Sevilla, E Escrich, ... European journal of cancer 37 (3), 402-413, 2001 | 201 | 2001 |
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. H Gómez, M Hidalgo, L Casanova, R Colomer, DL Pen, J Otero, ... Journal of Clinical Oncology 16 (6), 2065-2069, 1998 | 200 | 1998 |
Mediterranean diet, olive oil and cancer R Colomer, JA Menéndez Clinical and Translational Oncology 8, 15-21, 2006 | 191 | 2006 |